Arkolith/Insider Trading/ALXO/Form 4

Randolph Sophia

CHIEF MEDICAL OFFICER, DirectorALX ONCOLOGY HOLDINGS INC (ALXO) · full profile →Form 4 · filed May 15, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$191K
Net Open-Market Flow
-$191K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 13, 2024Sell(S)10K$15.82$161K332K
May 13, 2024Sell(S)2K$16.67$30K330K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-013237) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML